The aim of study is to describe the clinical, immunological, serological, virological and therapeutic characteristics of HIV+ patients harboring isolated anti-HBc profile and to assess the response to vaccination in these patients.
Study Type
OBSERVATIONAL
Enrollment
55
Chu Dijon
Dijon, France
Evaluation of immunological, virological and serological characteristics associated to "anti-HBc isolated" profile
Time frame: at Day 0, inclusion visite
Average titers of anti-HBs Ab
Time frame: at 4 weeks, 28 weeks and 18 months after the first vaccination HBV
Analysis of B-cell phenotype and maturation
Time frame: at baseline and at week 28
Number of patients with HBsAb titers as protective titer>10 IU/L
Time frame: at 4 weeks,28 weeks and 18 month after the first dose HBV vaccin
Detection of IgG+ memory B cells specific for HBcAg or HBs Ag
Time frame: at baseline and 28 weeks after the first dose HBV vaccin
- Detection of HBV preS2 and S-specific T cells
Time frame: at day 0 and week 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.